2022
DOI: 10.1016/j.micromeso.2022.112008
|View full text |Cite
|
Sign up to set email alerts
|

Iron oxide nanoparticle encapsulated; folic acid tethered dual metal organic framework-based nanocomposite for MRI and selective targeting of folate receptor expressing breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(10 citation statements)
references
References 56 publications
0
10
0
Order By: Relevance
“…Pandit et al [ 133 ] synthesized a dual MOF (ZIF‐67‐ZIF‐8) encapsulating iron oxide (IO) and coated with FA as receptor, which was subsequently loaded with Quercetin (Q) as a model drug. Owed to the presence of IO, a superparamagnetic material, the complex had the potential to be used for MRI.…”
Section: Drug‐loaded Mofs For Cancer Treatmentmentioning
confidence: 99%
“…Pandit et al [ 133 ] synthesized a dual MOF (ZIF‐67‐ZIF‐8) encapsulating iron oxide (IO) and coated with FA as receptor, which was subsequently loaded with Quercetin (Q) as a model drug. Owed to the presence of IO, a superparamagnetic material, the complex had the potential to be used for MRI.…”
Section: Drug‐loaded Mofs For Cancer Treatmentmentioning
confidence: 99%
“…In another study, Pandit et al successfully developed a folate acid-functionalized Fe 3 O 4 @MOF nanoprobe for MRI of folate receptor-expressing breast cancer cells. 155 Fe 3 O 4 nanoparticles were firstly synthesized by using citrate as the stabilizer and then used to mediate the nucleation and growth of MOFs. Furthermore, folate acid was functionalized with MOF nanocomposites to selectively target folate receptor-expressing breast cancer cells.…”
Section: Biomedical Applications Of Mof Nanocompositesmentioning
confidence: 99%
“…Metal–organic frameworks (MOFs) are becoming a promising tool for drug delivery applications. Pandit et al [ 115 ] reported the development and fabrication of a dual MOF composite with encapsulated iron oxide (IO) nanoparticles coated with folic acid (FA) as the targeting agent and quercetin (Q) as the drug agent. Due to the presence of SPION, composites inherently show potential use for MRI.…”
Section: Synthetic Magnetic Nanoparticlesmentioning
confidence: 99%